Literature DB >> 7685809

Inhibition of duck hepatitis B virus replication by interferon-gamma.

J E Lavine1, D Ganem.   

Abstract

Interferons have been evaluated extensively as candidate antiviral agents in hepadnaviral infection. We examined the effect of recombinant human interferon-gamma on duck hepatitis B virus replication in human hepatoma cells (Huh 7) transiently transfected with cloned duck hepatitis B virus DNA. Cells transfected in the presence of interferon-gamma display a dose-dependent reduction in the levels of encapsidated replicative intermediates in the cytoplasm, as judged by Southern blotting of purified viral core DNA. The effect is observed at interferon-gamma concentrations that do not affect growth rate or viability of Huh 7 cells or their transfection efficiency. Northern analysis of duck hepatitis B virus transcripts in transfected cells demonstrated markedly diminished levels of pre- and subgenomic RNA in interferon-gamma-treated cells. Nuclear run-on analysis was performed to determine whether these transcripts were diminished due to decreased rates of transcription initiation or increased rates of RNA degradation. Levels of transcription initiation were unaffected by interferon-gamma, implying that duck hepatitis B virus transcripts in interferon-gamma-treated cells are degraded more rapidly than in untreated cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685809     DOI: 10.1002/jmv.1890400112

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.

Authors:  Mengji Lu; Beate Lohrengel; Gero Hilken; Thekla Kemper; Michael Roggendorf
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes.

Authors:  U Schultz; F V Chisari
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 3.  Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?

Authors:  Andreas Sauerbrei
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 4.  Avian Interferons and Their Antiviral Effectors.

Authors:  Diwakar Santhakumar; Dennis Rubbenstroth; Luis Martinez-Sobrido; Muhammad Munir
Journal:  Front Immunol       Date:  2017-01-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.